Rifampicin treatment of cutaneous leishmaniasis
- PMID: 7040263
- DOI: 10.1111/j.1365-4362.1982.tb00517.x
Rifampicin treatment of cutaneous leishmaniasis
Abstract
In a small-scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
